Alessandro Faroni, Richard JP Smith, Adam J Reid,

1 Blond McIndoe Laboratories, Institute of In fl ammation and Repair, University of Manchester, Manchester, UK

2 Department of Plastic Surgery & Burns, University Hospital of South Manchester, Manchester, UK

Adipose derived stem cells and nerve regeneration

Alessandro Faroni1, Richard JP Smith1, Adam J Reid1,2

1 Blond McIndoe Laboratories, Institute of In fl ammation and Repair, University of Manchester, Manchester, UK

2 Department of Plastic Surgery & Burns, University Hospital of South Manchester, Manchester, UK

Injuries to peripheral nerves are common and cause life-changing problems for patients alongside high social and health care costs for society. Current clinical treatment of peripheral nerve injuries predominantly relies on sacri fi cing a section of nerve from elsewhere in the body to provide a graft at the injury site. Much work has been done to develop a bioengineered nerve graft, precluding sacri fi ce of a functional nerve. Stem cells are prime candidates as accelerators of regeneration in these nerve grafts. This review examines the potential of adipose-derived stem cells to improve nerve repair assisted by bioengineered nerve grafts.

peripheral nerve injury; adipose derived stem cells; nerve guidance tubes; bioengineered nerve graft; axonal regeneration; Schwann cell; cell therapy; nerve repair

Funding: Smith RJP is supported by the Hargreaves and Ball trust. Faroni A and Reid AJ are supported by the National Institute for Health Research, the Academy of Medical Sciences and the British Society for Surgery of the Hand.

Faroni A, Smith RJP, Reid AJ. Adipose derived stem cells and peripheral nerve regeneration. Neural Regen Res. 2014;9(14)：1341-1346.

Introduction

Injuries to peripheral nerves are common presentations of trauma resulting in life-changing problems for patients alongside high social and health care costs for society (Noble et al., 1998; Zochodne, 2012). Peripheral nerves possess an intrinsic regenerative capability predominantly due to the plasticity of Schwann cells, the myelinating glia of the peripheral nervous system (PNS) (Chen et al., 2007). Nonetheless, functional recovery following nerve injury is often poor and alternatives to the current clinical treatments are being sought. In particular, in the repair of a nerve gap conventional treatment would sacri fi ce a length of nerve from elsewhere in the body to be used as a graft in the repair of a more functionally crucial defect. This has led to much work on developing a bioengineered nerve graft.

The development of bioengineered nerve grafts

Bioengineered nerve grafts consist of natural or synthetic nerve guidance tubes, and a multitude of experimental adjuncts have been considered including extracellular matrix molecules, growth factors, pharmaceutical adjuvants and transplanted cells in order to guide the regeneration of axons across nerve gaps (Bell and Haycock, 2012; Faroni et al., 2013a). Commercially available nerve conduits include polyglicolic acid (PGA, Neurotube®) (Weber et al., 2000; Shin et al., 2009), poly-lactic acid (PLA) (Evans et al., 1999; Evans et al., 2000), poly(L-lactide-co-glycolide) (PLGA) (Hadlock et al., 1998; Bini et al., 2004), as well as poly-ε-caprolactone (PCL, Neurolac®) (Bertleff et al., 2005; Sun et al., 2010a, 2010b) and poly-3-hydroxybutyrate (PHB) (Aberg et al., 2009). The clinical results of these nerve conduits has failed to match the results of nerve grafting, perhaps due to the fact that they do not attempt to address the biology of the Schwann cell. Schwann cells are a crucial component of peripheral nerve regeneration, releasing growth factors and assisting in re-myelination (Jessen and Mirsky, 2008). Conduits acting as a cellular scaffold will be all the more effective if transplanted cells, such as Schwann cells or similar alternatives, are translated into clinical practice.

Adipose-derived stem cells (ASCs) as an alternative to Schwann cells

The clinical translation of cell therapy in nerve injury has many issues to address before its clinical relevance can be assessed. The difficulties in the harvest and expansion of Schwann cells together with the morbidity of the donor nerve strongly limit their use towards nerve bioengineering (Tohill and Terenghi, 2004; Kingham et al., 2007). In the search of the ideal alternative to Schwann cells for peripheral nerve regeneration, many alternatives have been evaluated, especially in the fi eld of stem cell research (Terenghi et al., 2009). Embryonic stem cells (ESC) (Cui et al., 2008; Ziegler et al., 2011), induced pluripotent stem cells (iPSC) (Lee et al., 2010; Kreitzer et al., 2013; Ikeda et al., 2014), and also mesenchymal adult stem cells (MSC) from various niches (that is bone marrow, fat, umbilical cord, dental pulp, skin) (McKenzie et al., 2006; Matsuse et al., 2010; Wakao et al., 2010; di Summa et al., 2011; Martens et al., 2014) have all been shown to be potential candidates as transplantable differentiated Schwann cell-like cells in nerve guidance tubesfor nerve regeneration. In particular adipose tissue, deriving from the embryonic mesenchyme, can be easily harvested and digested in order to obtain a stromal vascular fraction (SVF), containing a population of ASCs, which have shown multipotential capability (Zuk et al., 2002).

Indeed, ASCs can be differentiated in vitro towards adipogenic, osteogenic, chondrogenic, myogenic, and neurogenic lineages (Zuk et al., 2002; Gimble and Guilak, 2003). The expression profile of cell-surface markers of ASCs showed high similarities with bone marrow derived MSC (BMMSC) (Gronthos et al., 2001; Zuk et al., 2001, 2002). For instance, ASCs are positive for CD9, CD29, CD44, CD71, CD73, CD90 and CD105, but negative for CD11b, CD14, CD18, CD31, CD45 and CD56 (Gronthos et al., 2001; Zuk et al., 2001, 2002; Gimble and Guilak, 2003). One of the advantages of using ASCs and other stem cells for allogeneic transplantation is the low immunological pro fi le de fi ned by the low expression of HLA-DR class II histocompatibility antigens, and high expression of HDLA-ABC class I histocompatibility proteins (Aust et al., 2004). Furthermore, the number of fi broblast-like and alkaline-phosphatase-positive colony-forming units (CFU-F) is reported to be 600-fold higher in ASCs compared to BM-MSCs (Fraser et al., 2006), and they can be expanded faster and for longer periods (Kern et al., 2006; Locke et al., 2009).

ASCs and peripheral nerve regeneration

All these favourable properties have made ASCs a promising candidate for the engineering of several tissues, including injured peripheral nerves. In this context, both undifferentiated ASCs and differentiated Schwann cell-like ASCs (dASCs) have been assessed in in vitro and in vivo models of peripheral nerve regeneration. The results of various in vivo nerve regeneration studies investigating the regenerative potential of ASCs are summarised in Table 1. Nerve regeneration was hindered in vein conduits fi lled with lipoaspirates (Papalia et al., 2013), but cultured or uncultured ASCs isolated from the SVF, and seeded in PCL or silicon conduits, have been shown to promote nerve regeneration and to survive up to 12 weeks in vivo (Santiago et al., 2009; Suganuma et al., 2013). In particular ASCs facilitated the regeneration of a functional nerve and reduced muscular atrophy, but they did not directly differentiate into Schwann cells in vivo; furthermore there was evidence of undesired differentiation towards adipocytes, which may be detrimental for nerve regeneration (Santiago et al., 2009). ASCs have also been successfully used for re-populating de-cellularised nerve grafts used to repair rat nerve gap models (Liu et al., 2011; Luo et al., 2012). Moreover, transplanted ASCs have been shown to rescue the neuropathic phenotype of laminin-de fi cient mice, by facilitating sorting of axons and myelination (Carlson et al., 2011). Following systemic injection of ASCs, a few cells have been shown to migrate to the nerve injury site contributing to reduced in fl ammation and improved nerve regeneration (Marconi et al., 2012). The anatomical site of harvest (Kaewkhaw et al., 2011; Engels et al., 2013), the depth of the fat layer (Kalbermatten et al., 2011; Tremp et al., 2013), and the age of the donor (Mantovani et al., 2012; Sowa et al., 2012) are known to affect the neurotrophic potential of ASCs. Rather than a commitment to a Schwann cell phenotype, the positive effects of ASCs on neuronal protection and nerve regeneration in vivo and in vitro has been hypothesised to be associated with the release of growth factors, in particular nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and brain derived neurotrophic factor (BDNF) (Zhao et al., 2009; Luo et al., 2012; Sowa et al., 2012). This may be important for endogenous Schwann cell recruitment; even when a considerable number of cells are lost a few weeks following transplantation (Erba et al., 2010).

Schwann cell-like ASCs further improve nerve regeneration

A different strategy for the use of ASCs in nerve repair consists in the differentiation in vitro into a Schwann cell phenotype before transplantation. This could prevent the risk of teratomas and in vivo differentiation towards undesired phenotype, and could potentially generate committed Schwann cell-like cells able to actively participate in the regeneration and re-myelination of the injured nerves. Kingham et al. showed fi rst that rat ASCs could be differentiated into Schwann cell-like cells by exposure for two weeks to a cocktail of growth factors including fibroblast growth factor (FGF), plateled-derived growth factor (PDGF) and glial growth factor (Kingham et al., 2007). This differentiation mechanism, previously applied to bone marrow-derived MSC (Dezawa et al., 2001), mimic the environmental cues of Schwann cell development and it has been shown to be independent from notch signalling (Kingham et al., 2009). Schwann cell-like ASCs obtained by this means express glial markers, produce myelin proteins and release growth factors that are able to induce neurite sprouting in vitro (Kingham et al., 2007; Xu et al., 2008; Mantovani et al., 2010; de Luca et al., 2013). More recently, human Schwann cell-like ASCs have been shown to possess comparable molecular and functional properties (Tomita et al., 2013; Kingham et al., 2014). Schwann cell differentiation through the co-culture with primary Schwann cells or by the induction of neurosphere formation has also been successfully undertaken (Radtke et al., 2009; Wei et al., 2010; Razavi et al., 2012, 2013; Hsueh et al., 2014).

The potential of Schwann cell-like ASCs for nerve repair has been also demonstrated by several in vivo studies. These cells seeded in fi brin or silicon conduits have been shown to promote nerve regeneration and the functional outcome of nerve repair in 2 weeks (di Summa et al., 2010), 16 weeks (di Summa et al., 2011) and 6 months-long studies (Orbay et al., 2011). Nevertheless, they failed to enhance short-term nerve regeneration when seeded in commercially available collagen-based (Neuragen®) conduits (di Summa et al., 2014), unless dispersed in fi brin hydrogels (Carriel et al., 2013). Interestingly, magnetic resonance imaging (MRI) was proven effective to monitor the efficacy of Schwann cell-like ASCs to improve nerve growth, by monitoring the regenerating axon front over time (Tremp et al., 2013). Schwann cell-like ASCs have been successfully used to re-populate decellularised nerve allografts (Wang et al., 2012) or allogeneic arteryconduits (Sun et al., 2011) used for nerve repair. Another reported effect of the transplantation of Schwann cell-like ASCs for nerve repair is the reduction of neuronal loss at the level of the dorsal root ganglia (DRG) neurons, probably due to the delivery of growth factors that prevent the activation of caspase-3, which leads to cell death (Reid et al., 2011).

Table 1 Regenerative potential of adipose-derived stem cells (ASCs) in vivo

At the Blond McIndoe Laboratories we have focused recently on the investigation of novel pharmacological targets to improve the survival and neurotrophic potential of Schwann cell-like ASCs. In particular, we have shown that Schwann cell-like ASCs express several neurotransmitters receptors (that is γ-amino butyric acid GABA type-A and -B receptors, as well as the ionotropic P2X receptors for adenosine triphosphate, ATP), which can be stimulated in order to modulate cell death and survival, proliferation and expression or release of neurotrophic factors (NGF and BDNF) (Faroni et al., 2011, 2012, 2013b, c). In particular, stimulation with GABA-A agonists increases cell growth (Faroni et al., 2012), whereas GABA-B stimulation reduces dASC proliferation (Faroni et al., 2011) and induces increased expression of BDNF and NGF, suggesting improved differentiation (Faroni et al., 2013b). Similar effects have been previously reported in primary Schwann cells (Magnaghi et al., 2004), which are known to express GABA-B receptors that are also involved in differentiation and myelination (Magnaghi et al., 2008; Faroni et al., 2014b). Interestingly, we showed that specific inhibitors to P2X7receptors are able to rescue the ATP-evoked cell death, which may be partially responsible for the low survival rate of transplanted ASC at the site of nerve injury (Faroni et al., 2013c). This was also con fi rmed by Luo et al. (2013) in primary Schwann cells, and we have recently shown that P2X7receptors in Schwann cells control peripheral myelination (Faroni et al., 2014a). We believe that this evidence may point towards the development of novel approaches for nerve repair combining a cell-based therapy and pharmacological intervention.

Remaining clinical problems

Although ASCs have proved to be a promising tool for nerve repair, many questions remain before clinical translation could be considered. Firstly, it is still not clear if culturing and expanding the cells in vitro is bene fi cial for transplantation strategies, or if a more immediate approach, using SVF obtained and transplanted on the day of nerve repair, would be a better option. Secondly, although differentiation of ASCs has proven to be an effective means to improve their neuro-trophic potential, there is still little evidence that Schwann cell-like ASCs actively participate in the regeneration process by forming new myelin sheets. It seems, if anything, that their main role is to support endogenous Schwann cells by producing growth factors. In this scenario, it is worth considering what the bene fi ts are of delaying nerve repair to obtain a suf fi cient number of transplantable Schwann cell-like ASCs (meaning a reduced risk of undesired differentiation), or if it is feasible to develop protocols for direct trans-differentiation in vivo. Another aspect that should be considered when working with ASCs is the high heterogeneity of this particular stem cell population. It is known that the adherent cells obtained from the SVF contain different cell subpopulations differentially expressing several surface markers. From a clinical point of view, it would be of interest to identify the speci fi c subpopulation leading to the best outcome for nerve repair or generating better performing Schwann cell-like ASCs. Another area that could bene fi t from further investigation is to improve the interaction of ASCs with the different biomaterials that are currently used to generate nerve guides, by means of functionalization of the coating with biologically active substrates (Madduri et al., 2010). Finally, pharmacological intervention on ASCs has proven effective to improve survival and growth factor expression, thus further study on the identi fi cation of novel pharmacological targets on ASCs is worth further investigation.

Author contributions: Faroni A was the primary writer of the manuscript. Reid AJ contributed to generation of the schematics and revising the manuscript. Smith RJP contributed to review content compilation and revising the manuscript.

Con fl icts of interest:None declared.

Aberg M, Ljungberg C, Edin E, Millqvist H, Nordh E, Theorin A, Terenghi G, Wiberg M (2009) Clinical evaluation of a resorbable wrap-around implant as an alternative to nerve repair: a prospective, assessor-blinded, randomised clinical study of sensory, motor and functional recovery after peripheral nerve repair. J Plast Reconstr Aesthet Surg 62:1503-1509.

Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, Sen A, Willingmyre GD, Gimble JM (2004) Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6:7-14.

Bell JH, Haycock JW (2012) Next generation nerve guides: materials, fabrication, growth factors, and cell delivery. Tissue Eng Part B Rev 18:116-128.

Bertleff MJ, Meek MF, Nicolai JP (2005) A prospective clinical evaluation of biodegradable neurolac nerve guides for sensory nerve repair in the hand. T J Hand Surg Am 30:513-518.

Bini TB, Gao S, Xu X, Wang S, Ramakrishna S, Leong KW (2004) Peripheral nerve regeneration by microbraided poly(L-lactide-co-glycolide) biodegradable polymer fi bers. J Biomed Mater Res A 68:286-295.

Carlson KB, Singh P, Feaster MM, Ramnarain A, Pavlides C, Chen ZL, Yu WM, Feltri ML, Strickland S (2011) Mesenchymal stem cells facilitate axon sorting, myelination, and functional recovery in paralyzed mice de fi cient in Schwann cell-derived laminin. Glia 59:267-277.

Carriel V, Garrido-Gomez J, Hernandez-Cortes P, Garzon I, Garcia-Garcia S, Saez-Moreno JA, Del Carmen Sanchez-Quevedo M, Campos A, Alaminos M (2013) Combination of fi brin-agarose hydrogels and adipose-derived mesenchymal stem cells for peripheral nerve regeneration. J Neural Eng 10:026022.

Chen ZL, Yu WM, Strickland S (2007) Peripheral regeneration. Annu Rev Neurosci 30:209-233.

Cui L, Jiang J, Wei L, Zhou X, Fraser JL, Snider BJ, Yu SP (2008) Transplantation of embryonic stem cells improves nerve repair and functional recovery after severe sciatic nerve axotomy in rats. Stem Cells 26:1356-1365.

de Luca AC, Faroni A, Downes S, Terenghi G (2013) Differentiated adipose-derived stem cells act synergistically with RGD-modi fi ed surfaces to improve neurite outgrowth in a co-culture model. J Tissue Eng Regen Med [Epub ahead of print]. doi: 10.1002/term.1804.

Dezawa M, Takahashi I, Esaki M, Takano M, Sawada H (2001) Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci 14:1771-1776.

di Summa PG, Kingham PJ, Campisi CC, Raffoul W, Kalbermatten DF (2014) Collagen (NeuraGen(®)) nerve conduits and stem cells for peripheral nerve gap repair. Neurosci Lett 572:26-31.

di Summa PG, Kingham PJ, Raffoul W, Wiberg M, Terenghi G, Kalbermatten DF (2010) Adipose-derived stem cells enhance peripheral nerve regeneration. J Plast Reconstr Aesthet Surg 63:1544-1552.

di Summa PG, Kalbermatten DF, Pralong E, Raffoul W, Kingham PJ, Terenghi G (2011) Long-term in vivo regeneration of peripheral nerves through bioengineered nerve grafts. Neuroscience 181:278-291.

Engels PE, Tremp M, Kingham PJ, di Summa PG, Largo RD, Schaefer DJ, Kalbermatten DF (2013) Harvest site in fl uences the growth properties of adipose derived stem cells. Cytotechnology 65:437-445.

Erba P, Mantovani C, Kalbermatten DF, Pierer G, Terenghi G, Kingham PJ (2010) Regeneration potential and survival of transplanted undifferentiated adipose tissue-derived stem cells in peripheral nerve conduits. J Plast Reconstr Aesthet Surg 63:e811-817.

Evans GR, Brandt K, Widmer MS, Lu L, Meszlenyi RK, Gupta PK, Mikos AG, Hodges J, Williams J, Gurlek A, Nabawi A, Lohman R, Patrick CW, Jr. (1999) In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials 20:1109-1115.

Evans GR, Brandt K, Niederbichler AD, Chauvin P, Herrman S, Bogle M, Otta L, Wang B, Patrick CW, Jr. (2000) Clinical long-term in vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. J Biomater Sci Polym Ed 11:869-878.

Faroni A, Mantovani C, Shawcross SG, Motta M, Terenghi G, Magnaghi V (2011) Schwann-like adult stem cells derived from bone marrow and adipose tissue express gamma-aminobutyric acid type B receptors. J Neurosci Res 89:1351-1362.

Faroni A, Terenghi G, Magnaghi V (2012) Expression of functional gamma-aminobutyric acid type a receptors in Schwann-like adult stem cells. J Mol Neurosci 47:619-630.

Faroni A, Terenghi G, Reid AJ (2013a) Adipose-derived stem cells and nerve regeneration: promises and pitfalls. Int Rev Neurobiol 108:121-136.

Faroni A, Calabrese F, Riva MA, Terenghi G, Magnaghi V (2013b) Baclofen modulates the expression and release of neurotrophins in schwann-like adipose stem cells. J Mol Neurosci 49:233-243.

Faroni A, Rothwell SW, Grolla AA, Terenghi G, Magnaghi V, Verkhratsky A (2013c) Differentiation of adipose-derived stem cells into Schwann cell phenotype induces expression of P2X receptors that control cell death. Cell Death Dis 4:e743.

Faroni A, Smith RJ, Procacci P, Castelnovo LF, Puccianti E, Reid AJ, Magnaghi V, Verkhratsky A (2014a) Purinergic signaling mediated by P2X receptors controls myelination in sciatic nerves. J Neurosci Res [Epub ahead of print]. doi: 10.1002/jnr.23417.

Faroni A, Castelnovo LF, Procacci P, Caffino L, Fumagalli F, Melfi S, Gambarotta G, Bettler B, Wrabetz L, Magnaghi V (2014b) Deletion of GABA-B receptor in Schwann cells regulates remak bundles and small nociceptive C- fi bers. Glia 62:548-565.

Fraser JK, Schreiber R, Strem B, Zhu M, Alfonso Z, Wulur I, Hedrick MH (2006) Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc Med 3 Suppl 1:S33-37.

Gimble J, Guilak F (2003) Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5:362-369.

Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM (2001) Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189:54-63.

Hadlock T, Elisseeff J, Langer R, Vacanti J, Cheney M (1998) A tissue-engineered conduit for peripheral nerve repair. Arch Otolaryngol Head Neck Surg 124:1081-1086.

Hsueh YY, Chang YJ, Huang TC, Fan SC, Wang DH, Chen JJ, Wu CC, Lin SC (2014) Functional recoveries of sciatic nerve regeneration by combining chitosan-coated conduit and neurosphere cells induced from adipose-derived stem cells. Biomaterials 35:2234-2244.

Ikeda M, Uemura T, Takamatsu K, Okada M, Kazuki K, Tabata Y, Ikada Y, Nakamura H (2014) Acceleration of peripheral nerve regeneration using nerve conduits in combination with induced pluripotent stem cell technology and a basic fibroblast growth factor drug delivery system. J Biomed Mater Res A 102:1370-1378.

Jessen KR, Mirsky R (2008) Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56:1552-1565.

Kaewkhaw R, Scutt AM, Haycock JW (2011) Anatomical site in fl uences the differentiation of adipose-derived stem cells for Schwann-cell phenotype and function. Glia 59:734-749.

Kalbermatten DF, Schaakxs D, Kingham PJ, Wiberg M (2011) Neurotrophic activity of human adipose stem cells isolated from deep and super fi cial layers of abdominal fat. Cell Tissue Res 344:251-260.

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.

Kingham PJ, Kalbermatten DF, Mahay D, Armstrong SJ, Wiberg M, Terenghi G (2007) Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol 207:267-274.

Kingham PJ, Mantovani C, Terenghi G (2009) Notch independent signalling mediates Schwann cell-like differentiation of adipose derived stem cells. Neurosci Lett 467:164-168.

Kingham PJ, Kolar MK, Novikova LN, Novikov LN, Wiberg M (2014) Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair. Stem Cells Dev 23:741-754.

Kreitzer FR, Salomonis N, Sheehan A, Huang M, Park JS, Spindler MJ, Lizarraga P, Weiss WA, So PL, Conklin BR (2013) A robust method to derive functional neural crest cells from human pluripotent stem cells. Am J Stem Cells 2:119-131.

Lee G, Chambers SM, Tomishima MJ, Studer L (2010) Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 5:688-701.

Liu GB, Cheng YX, Feng YK, Pang CJ, Li Q, Wang Y, Jia H, Tong XJ (2011) Adipose-derived stem cells promote peripheral nerve repair. Arch Med Sci 7:592-596.

Locke M, Windsor J, Dunbar PR (2009) Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 79:235-244.

Luo H, Zhang Y, Zhang Z, Jin Y (2012) The protection of MSCs from apoptosis in nerve regeneration by TGFbeta1 through reducing infl ammation and promoting VEGF-dependent angiogenesis. Biomaterials 33:4277-4287.

Luo J, Lee S, Wu D, Yeh J, Ellamushi H, Wheeler AP, Warnes G, Zhang Y, Bo X (2013) P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord. Cell Death Dis 4:e829.

Madduri S, Papaloizos M, Gander B (2010) Trophically and topographically functionalized silk fi broin nerve conduits for guided peripheral nerve regeneration. Biomaterials 31:2323-2334.

Magnaghi V, Ballabio M, Cavarretta IT, Froestl W, Lambert JJ, Zucchi I, Melcangi RC (2004) GABAB receptors in Schwann cells in fl uence proliferation and myelin protein expression. Eur J Neurosci 19:2641-2649.

Magnaghi V, Ballabio M, Camozzi F, Colleoni M, Consoli A, Gassmann M, Lauria G, Motta M, Procacci P, Trovato AE, Bettler B (2008) Altered peripheral myelination in mice lacking GABAB receptors. Mol Cell Neurosci 37:599-609.

Mantovani C, Mahay D, Kingham M, Terenghi G, Shawcross SG, Wiberg M (2010) Bone marrow- and adipose-derived stem cells show expression of myelin mRNAs and proteins. Regen Med 5:403-410.

Mantovani C, Raimondo S, Haneef MS, Geuna S, Terenghi G, Shawcross SG, Wiberg M (2012) Morphological, molecular and functional differences of adult bone marrow- and adipose-derived stem cells isolated from rats of different ages. Exp Cell Res 318:2034-2048.

Marconi S, Castiglione G, Turano E, Bissolotti G, Angiari S, Farinazzo A, Constantin G, Bedogni G, Bedogni A, Bonetti B (2012) Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Eng Part A 18:1264-1272.

Martens W, Sanen K, Georgiou M, Struys T, Bronckaers A, Ameloot M, Phillips J, Lambrichts I (2014) Human dental pulp stem cells can differentiate into Schwann cells and promote and guide neurite outgrowth in an aligned tissue-engineered collagen construct in vitro. FASEB J 28:1634-1643.

Matsuse D, Kitada M, Kohama M, Nishikawa K, Makinoshima H, Wakao S, Fujiyoshi Y, Heike T, Nakahata T, Akutsu H, Umezawa A, Harigae H, Kira J, Dezawa M (2010) Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration. J Neuropathol Exp Neurol 69:973-985.

McKenzie IA, Biernaskie J, Toma JG, Midha R, Miller FD (2006) Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci 26:6651-6660.

Noble J, Munro CA, Prasad VS, Midha R (1998) Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma 45:116-122.

Orbay H, Uysal AC, Hyakusoku H, Mizuno H (2011) Differentiated and undifferentiated adipose-derived stem cells improve function in rats with peripheral nerve gaps. J Plast Reconstr Aesthet Surg 65:657-664.

Papalia I, Raimondo S, Ronchi G, Magaudda L, Giacobini-Robecchi MG, Geuna S (2013) Repairing nerve gaps by vein conduits filled with lipoaspirate-derived entire adipose tissue hinders nerve regeneration. Ann Anat 195:225-230.

Radtke C, Schmitz B, Spies M, Kocsis JD, Vogt PM (2009) Peripheral glial cell differentiation from neurospheres derived from adipose mesenchymal stem cells. Int J Dev Neurosci 27:817-823.

Razavi S, Ahmadi N, Kazemi M, Mardani M, Esfandiari E (2012) Ef ficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases. Adv Biomed Res 1:12.

Razavi S, Mardani M, Kazemi M, Esfandiari E, Narimani M, Esmaeili A, Ahmadi N (2013) Effect of leukemia inhibitory factor on the myelinogenic ability of Schwann-like cells induced from human adipose-derived stem cells. Cell Mol Neurobiol 33:283-289.

Reid AJ, Sun M, Wiberg M, Downes S, Terenghi G, Kingham PJ (2011) Nerve repair with adipose-derived stem cells protects dorsal root ganglia neurons from apoptosis. Neuroscience 199:515-522.

Santiago LY, Clavijo-Alvarez J, Bray fi eld C, Rubin JP, Marra KG (2009) Delivery of adipose-derived precursor cells for peripheral nerve repair. Cell Transplant 18:145-158.

Shin RH, Friedrich PF, Crum BA, Bishop AT, Shin AY (2009) Treatment of a segmental nerve defect in the rat with use of bioabsorbable synthetic nerve conduits: a comparison of commercially available conduits. J Bone Joint Surg Am 91:2194-2204.

Sowa Y, Imura T, Numajiri T, Nishino K, Fushiki S (2012) Adipose-derived stem cells produce factors enhancing peripheral nerve regeneration: in fl uence of age and anatomic site of origin. Stem Cells Dev 21:1852-1862.

Suganuma S, Tada K, Hayashi K, Takeuchi A, Sugimoto N, Ikeda K, Tsuchiya H (2013) Uncultured adipose-derived regenerative cells promote peripheral nerve regeneration. J Orthop Sci 18:145-151.

Sun F, Zhou K, Mi WJ, Qiu JH (2011) Combined use of decellularized allogeneic artery conduits with autologous transdifferentiated adipose-derived stem cells for facial nerve regeneration in rats. Biomaterials 32:8118-8128.

Sun M, McGowan M, Kingham PJ, Terenghi G, Downes S (2010a) Novel thin-walled nerve conduit with microgrooved surface patterns for enhanced peripheral nerve repair. J Mater Sci Mater Med 21:2765-2774.

Sun M, Kingham PJ, Reid AJ, Armstrong SJ, Terenghi G, Downes S (2010b) In vitro and in vivo testing of novel ultrathin PCL and PCL/ PLA blend fi lms as peripheral nerve conduit. J Biomed Mater Res A 93:1470-1481.

Terenghi G, Wiberg M, Kingham PJ (2009) Chapter 21: Use of stem cells for improving nerve regeneration. Int Rev Neurobiol 87:393-403.

Tohill M, Terenghi G (2004) Stem-cell plasticity and therapy for injuries of the peripheral nervous system. Biotechnol Appl Biochem 40:17-24.

Tomita K, Madura T, Sakai Y, Yano K, Terenghi G, Hosokawa K (2013) Glial differentiation of human adipose-derived stem cells: Implications for cell-based transplantation therapy. Neuroscience 236:55-65.

Tremp M, Meyer Zu Schwabedissen M, Kappos EA, Engels PE, Fischmann A, Scherberich A, Schaefer DJ, Kalbermatten DF (2013) The regeneration potential after human and autologous stem cell transplantation in a rat sciatic nerve injury model can be monitored by MRI. Cell Transplant [Epub ahead of print]. doi: 10.3727/096368913X676934.

Wakao S, Hayashi T, Kitada M, Kohama M, Matsue D, Teramoto N, Ose T, Itokazu Y, Koshino K, Watabe H, Iida H, Takamoto T, Tabata Y, Dezawa M (2010) Long-term observation of auto-cell transplantation in non-human primate reveals safety and ef fi ciency of bone marrow stromal cell-derived Schwann cells in peripheral nerve regeneration. Exp Neurol 223:537-547.

Wang Y, Zhao Z, Ren Z, Zhao B, Zhang L, Chen J, Xu W, Lu S, Zhao Q, Peng J (2012) Recellularized nerve allografts with differentiated mesenchymal stem cells promote peripheral nerve regeneration. Neurosci Lett 514:96-101.

Weber RA, Breidenbach WC, Brown RE, Jabaley ME, Mass DP (2000) A randomized prospective study of polyglycolic acid conduits for digital nerve reconstruction in humans. Plast Reconstr Surg 106:1036-1045; discussion 1046-1038.

Wei Y, Gong K, Zheng Z, Liu L, Wang A, Zhang L, Ao Q, Gong Y, Zhang X (2010) Schwann-like cell differentiation of rat adipose-derived stem cells by indirect co-culture with Schwann cells in vitro. Cell Prolif 43:606-616.

Xu Y, Liu L, Li Y, Zhou C, Xiong F, Liu Z, Gu R, Hou X, Zhang C (2008) Myelin-forming ability of Schwann cell-like cells induced from rat adipose-derived stem cells in vitro. Brain Res 1239:49-55.

Zhao L, Wei X, Ma Z, Feng D, Tu P, Johnstone BH, March KL, Du Y (2009) Adipose stromal cells-conditional medium protected glutamate-induced CGNs neuronal death by BDNF. Neurosci Lett 452:238-240.

Ziegler L, Grigoryan S, Yang IH, Thakor NV, Goldstein RS (2011) Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres. Stem Cell Rev 7:394-403.

Zochodne DW (2012) The challenges and beauty of peripheral nerve regrowth. J Peripher Nerv Syst 17:1-18.

Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.

Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.

10.4103/1673-5374.137585

Alessandro Faroni, Ph.D., Blond McIndoe Laboratories, Institute of Inflammation and Repair - University of Manchester, 3.107 Stopford Building, Oxford Road, Manchester M13 9PT, UK, alessandro.faroni@manchester.ac.uk.

http://www.nrronline.org/

Accepted: 2014-06-10